# CAVACURMIN (Curcuma longa)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/cavacurmin
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-28
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Curcuma longa, Curcuma longa L., turmeric extract, branded curcumin, standardized turmeric extract, curcumin formulation, turmeric rhizome extract

## Overview

CAVACURMIN is a patented curcumin extract derived from Curcuma longa, engineered using cyclodextrin complexation technology to dramatically improve the notoriously poor oral bioavailability of curcumin. Its primary bioactive compound, curcumin (diferuloylmethane), modulates NF-κB signaling, COX-2 enzyme activity, and [pro-inflammatory cytokine](/ingredients/condition/inflammation) cascades upon absorption.

## Health Benefits

• No clinical health benefits documented - research focuses solely on extraction methods
• No evidence quality available - no human trials conducted on CAVACURMIN
• No therapeutic outcomes reported - available data limited to extraction yields
• No meta-analyses or RCTs found - research dossier contains only extraction studies
• No specific health claims can be made based on provided research

## Mechanism of Action

Curcumin, the primary polyphenol in CAVACURMIN, inhibits IκB kinase (IKK), thereby suppressing NF-κB nuclear translocation and downstream transcription of inflammatory mediators including TNF-α, IL-1β, and IL-6. It also directly inhibits cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) enzymes, reducing [prostaglandin](/ingredients/condition/inflammation) E2 synthesis. The cyclodextrin complexation used in CAVACURMIN increases aqueous solubility of curcumin, theoretically improving intestinal absorption compared to unformulated curcumin powder.

## Clinical Summary

As of available research dossiers, no published human clinical trials have been conducted specifically on the CAVACURMIN trademarked formulation to evaluate therapeutic outcomes. Existing research on this ingredient is confined to in vitro extraction yield studies and solubility characterization data, meaning no randomized controlled trials (RCTs) or meta-analyses exist for this specific product. While the broader curcumin literature includes hundreds of human trials examining [inflammation](/ingredients/condition/inflammation), joint health, and metabolic parameters, these findings cannot be directly extrapolated to CAVACURMIN without formulation-specific bioavailability and efficacy data. Evidence strength for CAVACURMIN-specific health claims must currently be rated as insufficient.

## Nutritional Profile

CAVACURMIN is a specialized curcumin extract derived from Curcuma longa (turmeric) root, formulated using cavitation-based extraction technology to enhance bioavailability. Primary bioactive compound: curcuminoids complex comprising curcumin (typically 75-85% of curcuminoid fraction), demethoxycurcumin (15-20%), and bisdemethoxycurcumin (3-5%), with total curcuminoid concentration standardized typically to 95% curcuminoids by weight in the extract form. The cavitation extraction process is specifically designed to increase water dispersibility and oral bioavailability of curcumin, which in its native form has poor aqueous solubility (<1 mg/L) and limited intestinal absorption. Essential oils from Curcuma longa present in base material include ar-turmerone, turmerone, and zingiberene at trace concentrations. Naturally occurring micronutrients from turmeric source material include manganese (approximately 19.8 mg per 100g raw turmeric), iron (3.1 mg/100g), potassium (429 mg/100g), and vitamin C (approximately 25.9 mg/100g), though these are significantly concentrated or diluted depending on extraction ratio. Dietary fiber is largely removed during the extraction and concentration process. Protein content in the isolated extract is minimal (<1%). Bioavailability note: the cavitation process enhances curcumin's plasma absorption relative to unformulated curcumin, which typically demonstrates less than 1% oral bioavailability; however, specific pharmacokinetic parameters (Cmax, AUC) for CAVACURMIN specifically are derived from extraction methodology studies rather than human clinical trials.

## Dosage & Preparation

No clinically studied dosage ranges are available for CAVACURMIN as no human trials have been conducted. The research provides no information on standardization, forms (extract, powder), or therapeutic doses. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

General curcumin supplementation at doses up to 8,000 mg/day has demonstrated acceptable tolerability in short-term human studies, with the most commonly reported adverse effects being gastrointestinal in nature, including nausea, diarrhea, and bloating. Curcumin exhibits antiplatelet and anticoagulant properties, creating a clinically relevant interaction risk with warfarin, aspirin, clopidogrel, and other blood-thinning agents. It may also inhibit CYP3A4 and P-glycoprotein, potentially altering plasma concentrations of drugs metabolized via these pathways, including certain immunosuppressants and chemotherapy agents. Pregnant individuals should avoid high-dose curcumin supplementation due to its historical use as an emmenagogue and lack of established safety data in pregnancy.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found for CAVACURMIN in the research dossier. All available studies focus exclusively on extraction methods and yields without any therapeutic efficacy testing or clinical outcomes. No PubMed PMIDs are provided for any clinical studies.

## Historical & Cultural Context

Curcuma longa (turmeric) rhizomes have historical use in traditional medicine systems. However, the research dossier provides no specific details about duration of use, traditional medicine systems like Ayurveda, or traditional therapeutic applications beyond noting the plant as the source material.

## Synergistic Combinations

No synergistic ingredients identified in research

## Frequently Asked Questions

### What makes CAVACURMIN different from regular curcumin powder?

CAVACURMIN uses cyclodextrin complexation technology, which encapsulates curcumin molecules within cyclodextrin rings to increase aqueous solubility. Standard curcumin powder has less than 1% oral bioavailability due to poor water solubility and rapid intestinal metabolism, and cyclodextrin complexation is designed to address this limitation. However, no published human pharmacokinetic trials specific to CAVACURMIN have confirmed a quantified bioavailability advantage over unformulated curcumin.

### Are there any human clinical trials on CAVACURMIN?

No published human clinical trials have been identified specifically for the CAVACURMIN trademarked formulation as of available data. The research dossier for this ingredient is limited to extraction methodology and solubility characterization studies. Consumers should not assume efficacy based on the broader curcumin literature, as bioavailability and clinical outcomes can differ substantially between curcumin formulations.

### What is the recommended dosage for CAVACURMIN?

No clinically validated dosage has been established for CAVACURMIN specifically, as no human dose-ranging or efficacy trials have been published. General curcumin bioavailability-enhanced formulations are commonly studied at doses ranging from 500 mg to 1,500 mg of curcumin equivalent per day. Any dosing guidance for CAVACURMIN should be taken directly from the manufacturer's specifications until independent clinical data becomes available.

### Can CAVACURMIN interact with medications?

Curcumin, the active compound in CAVACURMIN, has documented interactions with anticoagulant drugs such as warfarin and antiplatelet agents like aspirin and clopidogrel, potentially increasing bleeding risk. It also inhibits cytochrome P450 enzymes CYP3A4 and CYP1A2, and P-glycoprotein transporters, which can elevate or reduce plasma concentrations of co-administered pharmaceuticals. Individuals taking immunosuppressants, chemotherapy agents, or chronic cardiovascular medications should consult a physician before use.

### Is CAVACURMIN safe during pregnancy?

High-dose curcumin supplementation, including formulations like CAVACURMIN, is generally not recommended during pregnancy due to curcumin's historical classification as an emmenagogue, meaning it may stimulate uterine contractions at pharmacological doses. No safety data specific to CAVACURMIN in pregnant populations exists in the published literature. Culinary quantities of turmeric are considered safe, but concentrated supplement doses carry uncharacterized fetal risk and should be avoided without explicit medical supervision.

### What is the bioavailability of CAVACURMIN compared to standard curcumin?

CAVACURMIN is a branded extraction of Curcuma longa designed to enhance bioavailability through proprietary processing methods. While standard curcumin powder has notoriously poor absorption rates, CAVACURMIN's extraction technique aims to address this limitation, though independent bioavailability studies comparing it directly to other enhanced curcumin forms are limited. The specific advantages depend on the proprietary extraction process used by the manufacturer.

### How should CAVACURMIN be taken for optimal absorption?

CAVACURMIN, like other curcumin products, is fat-soluble and absorbs better when taken with dietary fats or oils. Taking CAVACURMIN with meals containing healthy fats can enhance its absorption significantly compared to taking it on an empty stomach. Consistency in timing and pairing with meals is more important than the specific time of day.

### What research exists on CAVACURMIN's extraction quality and purity?

Available research on CAVACURMIN focuses on extraction yields and processing methods rather than clinical health outcomes in humans. Published studies document the efficiency of the extraction technique and curcuminoid concentration levels achieved through the proprietary process. No independent third-party analyses of CAVACURMIN's purity or contaminant testing are readily available in public literature.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*